Rheinmetall's Cash Burn Tests the Bull Case Behind a 17% Weekly Surge

Rheinmetall shares closed Friday at EUR 1,090.20, up 5.4% on the day — a move that capped a 17% advance over the past seven trading sessions. The rally, which extends gains booked since the stock's low the previous week, was powered less by company news than by a sector-wide shift in sentiment: speculation that European defence budgets are about to translate into firmer orders.

Morgan Stanley gave that thesis a nudge. According to reporting from dpa-AFX, the US bank expects a pick-up in defence contract awards by year-end, a pattern its analysts believe could set off a seasonal rally across the sector. Traders moved quickly on the view, bidding up European defence names and lifting the Düsseldorf group along with them. Market watchers read the prospect of accelerated funding drawdowns as an important signal for the near-term order pipeline.

A Spanish Line, a Bigger Credit Facility, and a US Showcase

Operationally, the company had a busy stretch of its own. Rheinmetall commissioned a new medium-calibre components line at its Albacete site in Spain, a project carrying an investment of roughly EUR 20 million. The plant is designed to turn out about 1.2 million projectiles and 1.8 million cartridge cases a year, with the local workforce set to grow to 300 employees.

The group also moved to shore up its financial headroom, doubling an existing syndicated credit line from EUR 750 million to just over EUR 1.5 billion. And across the Atlantic, subsidiary American Rheinmetall presented selected systems for the US Army at the AUSA 2026 defence trade show, covering combat vehicles, air defence, ammunition and autonomous systems — a pitch aimed at future US procurement programmes.

The Number That Matters: Free Cash Flow

Yet for all the order-book momentum, one figure is drawing the most scrutiny from investors: operating free cash flow. The backlog hit a record EUR 80.47 billion at mid-year, but the group posted negative operating free cash flow of EUR 1.616 billion in the first half of 2026 — a steep deterioration from the EUR 631 million outflow recorded a year earlier.

The cash drain stems from a heavy build-up of inventories and advance spending on future deliveries. Shareholders now face a judgement call: whether that pre-funding of production soon converts into robust cash inflows, or whether working capital stays tied up longer than expected. The precautionary expansion of the credit line underscores just how capital-hungry this growth phase has become. Speed in converting orders into cash is emerging as the decisive test of whether the current share price can hold.

Bulls Point to Capacity, Guidance and a EUR 100 Billion Target

Optimists lean on the growth trajectory and sustained demand from NATO members. Management is targeting full-year 2026 revenue of between EUR 13.7 billion and EUR 14.2 billion, alongside an operating margin of around 19%. By 2030, the company plans annual production capacity of 1.5 million rounds of 155mm artillery ammunition and four million medium-calibre components — scale effects that, if delivered on schedule, should lift profitability in the ammunition division further.

Analyst confidence remains widespread. JPMorgan carries a price target of EUR 1,350 on the stock. A steady climb in orders toward the roughly EUR 100 billion envisaged for year-end could give the shares fresh impetus.

The Bear Case: Cancelled Programmes and Execution Risk

Not everyone shares the enthusiasm. The collapse of individual large projects has left marks: after the cancellation of the F126 programme, management trimmed its original 2026 revenue forecast from as much as EUR 14.5 billion. The aggressive ramp-up of production sites carries operational hazards of its own — supply-chain delays, shortages of qualified staff, or friction in integrating new manufacturing lines could put the ambitious margin targets at risk.

Berenberg downgraded the stock from "Buy" to "Hold" just over a week ago, cutting its price target from EUR 1,600 to EUR 1,020. Sceptics also note that the shares sit 17% below their 200-day moving average, and that the broader downtrend of recent months has not been fully reversed despite the latest gains.

Two Paths, One Date

From here, the setup splits cleanly. As long as the stock holds above the psychologically important EUR 1,000 mark and defence budgets convert into firm call-offs on schedule, the recovery has room to run. Should confidence in operating margins falter — or should it become clear that the cash outflow is staying elevated through the second half — a fresh slide toward the year's lows becomes the risk.

The next marker is already circled: on 5 November 2026, the board reports third-quarter figures, with margin development and cash generation squarely in the market's sights.